Saturday, 10 October 2026European Markets

BASSAC And CTP Have A High Dividend Yield And Return On Equity In The Real Estate - Development Industry.

Loading stream...

(vianews) - bassac (bass.pa) is among this list of stock assets with the highest dividend rate and return on equity on the real estate - development industry.

financial asset price forward dividend yield return on equity
bassac (bass.pa) €46.10 5.4% 13.22%
ctp (ctpnv.as) €15.80 3.23% 16.95%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. bassac (bass.pa)

5.4% forward dividend yield and 13.22% return on equity

bassac société anonyme operates as a real estate development company primarily in france, belgium, germany, and spain. it offers residential buildings and houses, and commercial real estate, as well as prefabricated garages and land. the company was incorporated in 1972 and is headquartered in boulogne-billancourt, france. as of december 31, 2021, bassac société anonyme operates as a subsidiary of premier investissement sas.

earnings per share

as for profitability, bassac has a trailing twelve months eps of €5.81.

pe ratio

bassac has a trailing twelve months price to earnings ratio of 7.93. meaning, the purchaser of the share is investing €7.93 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.22%.

revenue growth

year-on-year quarterly revenue growth declined by 1.4%, now sitting on 1.29b for the twelve trailing months.

more news about bassac.

2. ctp (ctpnv.as)

3.23% forward dividend yield and 16.95% return on equity

ctp n.v. owns, develops, manages, and leases logistics and industrial real estate properties in central, western, and eastern europe. the company offers various building for small and growing businesses, global enterprises, built to suit, and other offices. it also develops urban parks which are harbour mixed-use building and space types, such as premium offices, retail stores, office services, public spaces, and other amenities. ctp n.v. was founded in 1998 and is based in amsterdam, the netherlands. ctp n.v. (enxtam:ctpnv) operates as a subsidiary of ctp holding b.v.

earnings per share

as for profitability, ctp has a trailing twelve months eps of €2.08.

pe ratio

ctp has a trailing twelve months price to earnings ratio of 7.6. meaning, the purchaser of the share is investing €7.6 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.95%.

yearly top and bottom value

ctp's stock is valued at €15.80 at 11:40 est, under its 52-week high of €16.04 and way above its 52-week low of €11.12.

revenue growth

year-on-year quarterly revenue growth grew by 11%, now sitting on 647.31m for the twelve trailing months.

more news about ctp.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic Enterprise Software Consolidates: Big Platforms Push Autonomy While Startups Get Absorbed
Enterprise software is shifting toward autonomous, AI-agent-driven products. SAP (Autonomous Enterprise, Joule), Meta (a new Enterprise Platform led by ex-MongoDB CEO Chirantan Desai) and UiPath (raised guidance) are pushing from the top. Meanwhile AI-security and governance startups are being acquired (Fortinet–Virtue AI, Harvey–Guardrails AI, Tiny–Oso Cloud) and seed-stage agent companies keep raising capital (Dextr, Latitude, Groq). Investors such as Norwest's Sean Jacobsohn see finance and ERP back-office software as the easier area to disrupt. Trust and enforced governance are treated as preconditions for regulated sectors like finance, and AI is judged unreliable for calculations.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,366 source documents archived
Query this data → isubstrate.com